MBX Biosciences, Inc.
MBX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2024 | Q1 2023 |
|---|---|---|
| Net Income | -$12.34M | -$5.95M |
| EPS Diluted | -$10.26 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
MBX Biosciences, Inc. · CIK 1776111 · Engraved from SEC EDGAR